Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
Daicel ( (JP:4202) ) has provided an update.
Daicel Corporation announced corrections to its consolidated financial results for the fiscal year ended March 31, 2024. The corrections pertain to errors found in the ‘Investment in equity method investees’ under segment information, which have been rectified to ensure accurate financial reporting. This announcement underscores Daicel’s commitment to transparency and accuracy in its financial disclosures, which is crucial for maintaining stakeholder trust and ensuring proper market positioning.
The most recent analyst rating on (JP:4202) stock is a Buy with a Yen2040.00 price target. To see the full list of analyst forecasts on Daicel stock, see the JP:4202 Stock Forecast page.
More about Daicel
Daicel Corporation operates in the chemical industry, focusing on producing a range of products including medical and healthcare materials, smart safety materials, engineering plastics, and other specialized chemical products. The company is listed on the Prime Market of the Tokyo Stock Exchange.
Average Trading Volume: 684,408
Technical Sentiment Signal: Sell
Current Market Cap: Yen315.7B
For detailed information about 4202 stock, go to TipRanks’ Stock Analysis page.
Trending Articles:
Looking for a trading platform? Check out TipRanks' Best Online Brokers guide, and find the ideal broker for your trades.
Report an Issue